More on LGND
Data
Financials
Upcoming Events
News
Click line-items for a historical chart and %
| Net income (loss) | |
| Less: gain from discontinued operations | 731K |
| Income (loss) from continuing operations | |
| Accretion of deferred gain on sale leaseback | |
| Change in estimated fair value of contingent value rights | |
| Depreciation and amortization | 8.32M |
| Non-cash lease costs | |
| Gain on asset write-offs | |
| Realized gain on investment | |
| Stock-based compensation | 13.69M |
| Deferred income taxes | 347K |
| Other | |
| Accounts receivable, net | -411K |
| Inventory | -2.39M |
| Other current assets | -9K |
| Other long term assets | -31K |
| Accounts payable and accrued liabilities | -3.08M |
| Other liabilities | |
| Deferred revenue | 1.5M |
| Net cash used in operating activities of continuing operations | |
| Net cash provided by operating activities of discontinued operations | |
| Net cash used in operating activities | 42.01M |
| Purchases of property and equipment | -1.78M |
| Acquisition of CyDex, net of cash acquired | |
| Acquisition of Metabasis, net of cash acquired | -92.5M |
| Acquisition of intellectual property | |
| Purchases of short-term investments | -73.11M |
| Proceeds from sale of short-term investments | 23.39M |
| Proceeds from sale of property and equipment and building | |
| Other, net | |
| Net cash provide by (used in) investing activities of continuing operations | |
| Net cash provided by investing activities of discontinued operations | |
| Net cash provided by (used in) investing activities | -56.47M |
| Proceeds from issuance of debt | |
| Share repurchases | 0 |
| Principal payments on equipment financing obligations | |
| Net proceeds from issuance of common stock | |
| Net cash provided by financing activities | 3.61M |
| Net increase (decrease) in cash and cash equivalents | -10.85M |
| Cash and cash equivalents at beginning of period | 97.43M |
| Cash and cash equivalents at end of period | 86.58M |
Entities mentioned with LGND
- Twitter | View Related Stories »
- Earnings | View Related Stories »
- Definitive Agreement | View Related Stories »
- FDA | View Related Stories »
- Roth Capital | View Related Stories »
- 13G | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- Show More...
